ADAGIO MEDICAL HOLDINGS, INC. SPECIAL MEETING OF STOCKHOLDERS - PARK NATIONAL CORP

Based on the provided transcript, the following is a summary of the Adagio Medical Holdings Special Stockholders Meeting.

Note: The transcript describes a procedural corporate meeting rather than a traditional earnings call; consequently, specific financial performance metrics (revenue, earnings, cash flow) and forward-looking business guidance were not disclosed in this text.

• Financial Performance:

  • No financial performance data (revenue, earnings, margins, cash flow, or debt) was discussed or reported in this transcript, as the meeting was a procedural vote rather than an earnings presentation.
  • Share count data provided: 27,439,328 shares outstanding on the record date (October 5, 2026); 14,237,725 votes received (approx. 51.88% quorum).

• Guidance and Future Outlook:

  • Management declined to provide specific forward guidance or updates regarding the company's "strategic process."
  • The Board stated it is focused on acting in the best interest of all shareholders but did not outline specific long-term goals beyond the immediate reverse stock split proposal.
  • No details were provided on future product launches, customer agreements, or market expansion strategies.

• Business Segments and Product Lines:

  • No information regarding business segments, product lines, new launches, or operational performance was included in the meeting.

• Market and Competitive Landscape:

  • The primary market driver mentioned is the necessity to regain and maintain compliance with NASDAQ listing requirements.
  • The proposed reverse stock split aims to raise the per-share trading price to meet listing standards, which typically involves a minimum share price requirement (implied context).

• Risks and Challenges:

  • Listing Compliance: The primary risk addressed is the potential non-compliance with NASDAQ listing rules regarding share count or price.
  • Uncertainty of Outcome: Management explicitly cautioned that there is no assurance the reverse split will achieve listing compliance or result in a post-split share price increase proportional to the reduction in shares outstanding.
  • Dilution/Conversion Requirements: A shareholder question noted concerns regarding the need for 200% of shares available for conversion relative to notes, which may be a compliance hurdle.

• Management Commentary and Tone:

  • Tone: The tone was strictly procedural, formal, and cautious.
  • Confidence: Management expressed a lack of confidence in the specific outcomes of the split, stating there is "no assurance" it will fix listing issues or boost the stock price.
  • Transparency: Management declined to comment on the broader strategic process, directing shareholders to the proxy statement for detailed information.

• Analyst Questions and Answers:

  • Question: One question was raised from the virtual floor regarding whether the reverse split was intended to bring the company in line with note requirements to have 200% of shares available for conversion.
  • Answer: Management confirmed the Board's objective is to regain/maintain NASDAQ listing compliance and generate investor interest but refused to comment further on the strategic process or specific note conversion dynamics.

• Other Key Points:

  • Meeting Purpose: This was a Special Stockholders Meeting to vote on a proposal for a reverse stock split (ratio between 1:10 and 1:500).
  • Voting Outcome: The proposal to amend the Certificate of Incorporation to effect the reverse stock split was approved.
  • Future Reporting: Preliminary voting results will be filed on Form 8K within four business days; final results will be reported in an amendment to the Form 8K shortly thereafter.
  • Record Date: The record date for shareholders eligible to vote was October 5, 2026.
  • Time and Attendance: Meeting held on October 23, 2026, at 8:00 a.m. Pacific Time; a quorum was reached with 51.88% of shares represented.